These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8439123)

  • 1. Placebos and principles: a trial of ondansetron.
    Citron ML
    Ann Intern Med; 1993 Mar; 118(6):470-1. PubMed ID: 8439123
    [No Abstract]   [Full Text] [Related]  

  • 2. When regulatory requirements conflict with ethical study design: the case of oral ondansetron.
    Markman M
    Cancer Invest; 1994; 12(6):654-6. PubMed ID: 7994600
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of delayed emesis caused by chemotherapy.
    Harmon D; O'Brien B
    N Engl J Med; 2000 Sep; 343(12):889; author reply 889-90. PubMed ID: 11001695
    [No Abstract]   [Full Text] [Related]  

  • 4. The control of delayed nausea.
    Roila F; Ballatori E
    Ann Oncol; 1997 Jun; 8(6):615-6. PubMed ID: 9261534
    [No Abstract]   [Full Text] [Related]  

  • 5. The ethics of placebos in AIDS drug trials.
    Porter JD; Forrest BD; Kennedy AR
    HEC Forum; 1992; 4(3):155-62. PubMed ID: 10120020
    [No Abstract]   [Full Text] [Related]  

  • 6. When placebo controlled trials are essential and equivalence trials are inadequate.
    Tramèr MR; Reynolds DJ; Moore RA; McQuay HJ
    BMJ; 1998 Sep; 317(7162):875-80. PubMed ID: 9748192
    [No Abstract]   [Full Text] [Related]  

  • 7. [ESMO 2004. Nausea and vomiting caused by chemotherapy: improving the treatment].
    Longo F; Mansueto G
    Tumori; 2005; 91(1):suppl 36-48. PubMed ID: 15850022
    [No Abstract]   [Full Text] [Related]  

  • 8. Ondansetron: a specific serotonin antagonist for the prevention of chemotherapy-induced vomiting.
    Kris MG
    Important Adv Oncol; 1994; ():165-77. PubMed ID: 8206488
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral ondansetron for preventing nausea and vomiting.
    Cooke CE; Mehra IV
    Am J Hosp Pharm; 1994 Mar; 51(6):762-71. PubMed ID: 8010314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT3 receptor antagonists in the control of cisplatin-induced delayed emesis.
    Ossi M; Anderson E; Freeman A
    Oncology; 1996 Jun; 53 Suppl 1():78-85. PubMed ID: 8692556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLINICAL DECISIONS. Chemotherapy-Induced Nausea and Vomiting.
    Wilbur MB; Birrer MJ; Spriggs DR
    N Engl J Med; 2016 Jul; 375(2):177-9. PubMed ID: 27410928
    [No Abstract]   [Full Text] [Related]  

  • 12. Placebo controlled trials of ondansetron for postoperative nausea and vomiting.
    Palmer JB; Gibbs TG; Taylor CM
    BMJ; 1996 Jan; 312(7024):183. PubMed ID: 8563554
    [No Abstract]   [Full Text] [Related]  

  • 13. Global experience with ondansetron and future potential.
    Butcher ME
    Oncology; 1993; 50(3):191-7. PubMed ID: 8459991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
    Kwong WJ; Parasuraman TV
    Pharm Pract Manag Q; 1999 Apr; 19(1):28-41. PubMed ID: 10351607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a triple antiemetic regimen with aprepitant for the prevention of chemotherapy-induced nausea and vomiting: effects of gender, age, and region.
    Rapoport BL
    Curr Med Res Opin; 2014 Sep; 30(9):1875-81. PubMed ID: 24911369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron].
    Czeglédi F; Baki M
    Orv Hetil; 1994 Oct; 135(44):2415-9. PubMed ID: 7970661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy.
    Italian Group for Antiemetic Research
    N Engl J Med; 2000 May; 342(21):1554-9. PubMed ID: 10824073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of ondansetron for chemotherapy-induced nausea and emesis.
    San Angel F
    J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials.
    Aspinall RL; Goodman NW
    BMJ; 1995 Sep; 311(7009):844-6. PubMed ID: 7580491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the control of chemotherapy-induced emesis.
    Perez EA; Gandara DR
    Ann Oncol; 1992 Aug; 3 Suppl 3():47-50. PubMed ID: 1390317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.